BIODYSSEY Trademark

Trademark Overview

On Wednesday, October 29, 2025, a trademark application was filed for BIODYSSEY with the United States Patent and Trademark Office. The USPTO has given the BIODYSSEY trademark a serial number of 99468511. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, March 20, 2026. This trademark is owned by Biodyssey Therapeutics, Inc.. The BIODYSSEY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Anticancer pharmaceutical compounds; therapeutic and diagnostic radiopharmaceutical preparations; diagnostic radiopharmaceutical preparations for clinical, medical and research use in the cancer treatments

Scientific research; Scientific research and development in the fields of oncology, radiopharmaceuticals, and cancer treatment; Pharmaceutical research and development of new radiopharmaceutical agents; Design and testing of radiopharmaceutical drugs for cancer diagnosis and therapy; Laboratory research, testing, and analysis in the field of nuclear medicine and targeted radiotherapy; Providing scientific information in the field of biochemistry, biotechnology, pharmaceutical research and development, and clinical trials; Scientific research consulting in the field of biotechnology, pharmaceutical research and development, and genetic science in relation to radiopharmaceuticals and cancer
biodyssey

General Information

Serial Number99468511
Word MarkBIODYSSEY
Filing DateWednesday, October 29, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, March 20, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkBIO ODYSSEY
Goods and ServicesAnticancer pharmaceutical compounds; therapeutic and diagnostic radiopharmaceutical preparations; diagnostic radiopharmaceutical preparations for clinical, medical and research use in the cancer treatments
Goods and ServicesScientific research; Scientific research and development in the fields of oncology, radiopharmaceuticals, and cancer treatment; Pharmaceutical research and development of new radiopharmaceutical agents; Design and testing of radiopharmaceutical drugs for cancer diagnosis and therapy; Laboratory research, testing, and analysis in the field of nuclear medicine and targeted radiotherapy; Providing scientific information in the field of biochemistry, biotechnology, pharmaceutical research and development, and clinical trials; Scientific research consulting in the field of biotechnology, pharmaceutical research and development, and genetic science in relation to radiopharmaceuticals and cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 29, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 29, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiodyssey Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVan Nuys, CA 91405
US

Trademark Events

Event DateEvent Description
Wednesday, October 29, 2025NEW APPLICATION ENTERED
Wednesday, October 29, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, February 11, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 13, 2026ASSIGNED TO EXAMINER
Friday, March 20, 2026NON-FINAL ACTION WRITTEN
Friday, March 20, 2026NON-FINAL ACTION E-MAILED
Friday, March 20, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

biodyssey research cancer development radiopharmaceutical scientific pharmaceutical field biotechnology diagnostic testing